India and Egypt Join Forces to Drive Pharmaceutical Growth and Innovation Through Strategic Delegation Visit

In a significant step towards strengthening bilateral ties between India and Egypt, a high-level delegation led by the Director General of Pharmexcil, Mr. Raja Bhanu, and supported by Suresh K. Reddy, Ambassador of India to Egypt, engaged with key stakeholders in Egypt’s growing pharmaceutical sector.

The event, aimed at deepening collaboration between the two nations in the healthcare and pharmaceutical industries, marks a pivotal moment in the strengthening of trade and investment ties.

The Indian delegation, which includes prominent figures from the pharmaceutical industry, seeks to explore and expand opportunities for joint ventures, technology sharing, and capacity-building in Egypt’s thriving pharmaceutical market.

The Egyptian market, forecasted to grow from USD 5.1 billion in 2024-2025 to USD 5.7 billion in 2025-2026, presents a wealth of opportunities, particularly in the areas of generics, biosimilars, and vaccines, where India excels.

Suresh K. Reddy, Ambassador of India to Egypt, expressed his optimism about the growing relationship between the two countries, “India has long been a trusted partner in the global pharmaceutical industry, and Egypt’s dynamic healthcare sector presents an ideal opportunity for enhanced cooperation. The Embassy is committed to facilitating partnerships between Indian pharmaceutical companies and their Egyptian counterparts, ensuring that the benefits of our collaboration are felt not only in our two countries but across the broader MENA region.”

During the event, Mr. Raja Bhanu, Director General of Pharmexcil, highlighted the immense potential for India to support Egypt’s pharmaceutical growth. “India’s pharmaceutical industry is renowned for its ability to provide high-quality, affordable medicines. As Egypt continues to expand its healthcare coverage and local manufacturing capabilities, Indian companies are well-positioned to collaborate with Egyptian firms, contributing to the shared goal of ensuring access to essential healthcare products for all citizens,” said Mr. Bhanu.

The collaboration aims to focus on a wide range of areas, including generic medicines, clinical research, biotechnology, and vaccine production. Both nations aim to explore joint ventures in pharmaceutical manufacturing and R&D, helping Egypt become a hub for pharmaceutical trade and production. The event marked the beginning of several initiatives intended to drive investments, foster knowledge exchange, and accelerate progress in healthcare innovation.

The Embassy of India and Pharmexcil will continue to work together to support the growth of India-Egypt partnerships, ensuring that both nations benefit from the shared knowledge, expertise, and opportunities available within the pharmaceutical industry.

The Pharmaceuticals Export Promotion Council of India (Pharmexcil) is the apex export promotion council for the Drugs, Pharmaceutical & Healthcare industry in the global arena, established by the Ministry of Commerce & Industry, Government of India. It plays a crucial role in promoting Indian pharmaceutical exports, supporting exporters, and advancing bilateral market access and global pharmaceutical leadership. With over 4679+ members, PHARMEXCIL is mandated to help them achieve excellence in exports and facilitate overseas buyers to find suitable trade partners from the Indian pharma industry